Siguazodan

98%

  • Product Code: 109608
  CAS:    115344-47-3
Molecular Weight: 284.32 g./mol Molecular Formula: C₁₄H₁₆N₆O
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: Siguazodan is primarily used in research settings to study its effects on phosphodiesterase III (PDE III) inhibition. It has been investigated for its potential therapeutic applications in cardiovascular diseases, particularly in heart failure. The compound has shown promise in enhancing cardiac contractility and vasodilation, which can improve blood flow and overall heart function. Additionally, Siguazodan has been explored for its potential anti-inflammatory properties, making it a subject of interest in conditions where inflammation plays a key role. Its applications are largely confined to preclinical studies, aiming to better understand its mechanisms and potential benefits in various medical contexts.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days €620.19
+
-
Siguazodan
Siguazodan is primarily used in research settings to study its effects on phosphodiesterase III (PDE III) inhibition. It has been investigated for its potential therapeutic applications in cardiovascular diseases, particularly in heart failure. The compound has shown promise in enhancing cardiac contractility and vasodilation, which can improve blood flow and overall heart function. Additionally, Siguazodan has been explored for its potential anti-inflammatory properties, making it a subject of interest in conditions where inflammation plays a key role. Its applications are largely confined to preclinical studies, aiming to better understand its mechanisms and potential benefits in various medical contexts.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: €0.00
€0.00 Total :